Extracting Maximum Value from Your Artifacts
Tip 25 in the Interoperability Tip Series This is our last tip in the Interoperability Tip Series. Read the entire series here. The fact is
Home » Interoperability Tip Series
Tip 25 in the Interoperability Tip Series This is our last tip in the Interoperability Tip Series. Read the entire series here. The fact is
Tip 24 in the Interoperability Tip Series Read Part 1 here In our previous tip we asked: why document HL7 profiles and specs. In beginning
Tip 23 in the Interoperability Tip Series The last few tips have been about what to document and how to document. This one and the
Tip 22 in the Interoperability Tip Series In the previous tip, we talked about documenting your interfaces and workflows – especially important for HIE organizations.
Tip 21 in the Interoperability Tip Series This tip is especially relevant for Healthcare Information Exchanges (HIEs), regardless of whether your exchange is internal to
Tip 20 in the Interoperability Tip Series In our previous tip, we explained why you need to map processes and workflows. Many developers list their
Tip 19 in the Interoperability Tip Series Throughout the Interoperability Tip Series, we’ve stressed the need to complement the message structure and and content details
Tip 18 in the Interoperability Series What’s The Big Deal? If you’re just getting your feet wet with clinical and medical applications, you might think:
Tip 17 in the Interoperability Tip Series HL7 Data for Testing In last week’s tip on HL7 test reporting, we suggested that you use production
Tip 16 in the Interoperability Tip Series The past few tips have covered HL7 testing and test automation. This one covers what you should do
NORTH AMERICA: +1 (877)-872-0027
WORLD: 1-418-872-4000
EMAIL: info@caristix.com
ASIA-PACIFIC
DENIS CANTIN
T: +61418441388
denis.cantin@caristix.com
NORTH AMERICA & EUROPE
JEAN-LUC MORIN
T: 418 872-4000
jeanluc.morin@caristix.com
HL7® / FHIR® are a registered trademarks of Health Level Seven International. The use of this trademark does not constitute an endorsement by HL7.